In the treatment group receiving oHSV + Fn-OMV + PD-L1, abscopal activity was observed with the rejection of a second flank tumor following injection of the primary flank tumor (Supplementary Fig. 17a–c). This evidence concerns the gene FN1 and neoplasm.